 Connection
Nicole Gonzales to Fibrinolytic Agents
This is a "connection" page, showing publications Nicole Gonzales has written about Fibrinolytic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.566 |
|
|
|
-
Navalkele DD, Cai C, Vahidy F, Rahbar MH, Pandurengan R, Wu TC, Sarraj A, Barreto A, Grotta JC, Gonzales N. Higher prehospital blood pressure prolongs door to needle thrombolysis times: a target for quality improvement? Am J Emerg Med. 2016 Jul; 34(7):1268-72.
Score: 0.449
-
Gonzales NR, Grotta JC. Alteplase for acute ischemic stroke. Expert Rev Cardiovasc Ther. 2006 May; 4(3):301-18.
Score: 0.225
-
Yaghi S, Willey JZ, Cucchiara B, Goldstein JN, Gonzales NR, Khatri P, Kim LJ, Mayer SA, Sheth KN, Schwamm LH. Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017 12; 48(12):e343-e361.
Score: 0.125
-
Darger B, Gonzales N, Banuelos RC, Peng H, Radecki RP, Doshi PB. Outcomes of Patients Requiring Blood Pressure Control Before Thrombolysis with tPA for Acute Ischemic Stroke. West J Emerg Med. 2015 Dec; 16(7):1002-6.
Score: 0.110
-
Wu TC, Sitton C, Potter A, Bowry R, Sahota P, Cai C, Hui P, Chen Z, Gonzales N, Barreto A, Lopez G, Grotta JC, Savitz SI. CTP infarct core may predict poor outcome in stroke patients treated with IV t-PA. J Neurol Sci. 2014 May 15; 340(1-2):165-9.
Score: 0.097
-
Barreto AD, Alexandrov AV, Shen L, Sisson A, Bursaw AW, Sahota P, Peng H, Ardjomand-Hessabi M, Pandurengan R, Rahbar MH, Barlinn K, Indupuru H, Gonzales NR, Savitz SI, Grotta JC. CLOTBUST-Hands Free: pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke. Stroke. 2013 Dec; 44(12):3376-81.
Score: 0.095
-
Willey JZ, Khatri P, Khoury JC, Merino JG, Ford AL, Rost NS, Gonzales NR, Ali LK, Meyer BC, Broderick JP. Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network. J Stroke Cerebrovasc Dis. 2013 May; 22(4):318-22.
Score: 0.083
-
Paciaroni M, Balucani C, Agnelli G, Caso V, Silvestrelli G, Grotta JC, Demchuk AM, Sohn SI, Orlandi G, Leys D, Pezzini A, Alexandrov AV, Silvestrini M, Fofi L, Barlinn K, Inzitari D, Ferrarese C, Tassi R, Tsivgoulis G, Consoli D, Baldi A, Bovi P, Luda E, Galletti G, Invernizzi P, DeLodovici ML, Corea F, Del Sette M, Monaco S, Marcheselli S, Alberti A, Venti M, Acciarresi M, D'Amore C, Macellari F, Lanari A, Previdi P, Gonzales NR, Pandurengan RK, Vahidy FS, Sline M, Bal SS, Chiti A, Gialdini G, Dumont F, Cordonnier C, Debette S, Padovani A, Cerqua R, Bodechtel U, Kepplinger J, Nesi M, Nencini P, Beretta S, Trentini C, Martini G, Piperidou C, Heliopoulos I, D'Anna S, Cappellari M, Donati E, Bono G, Traverso E, Toni D. Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study. Stroke. 2012 Jan; 43(1):125-30.
Score: 0.082
-
Barreto AD, Martin-Schild S, Hallevi H, Morales MM, Abraham AT, Gonzales NR, Illoh K, Grotta JC, Savitz SI. Thrombolytic therapy for patients who wake-up with stroke. Stroke. 2009 Mar; 40(3):827-32.
Score: 0.068
-
Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS, Cacayorin ED, Grotta JC, Noser EA. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke. 2007 Jan; 38(1):80-4.
Score: 0.058
-
Navi BB, Bach I, Czap AL, Wang M, Yamal JM, Jacob AP, Parker SA, Rajan SS, Mir S, Sherman C, Willey JZ, Saver JL, Gonzalez MO, Singh N, Jones WJ, Ornelas D, Gonzales NR, Alexandrov AW, Alexandrov AV, Nour M, Spokoyny I, Mackey J, Collins SQ, Silnes K, Fink ME, English J, Barazangi N, Bratina PL, Volpi J, Rao CPV, Griffin L, Persse D, Grotta JC. Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. Ann Neurol. 2024 Feb; 95(2):347-361.
Score: 0.047
-
Pirlog BO, Jacob AP, Rajan SS, Yamal JM, Parker SA, Wang M, Bowry R, Czap A, Bratina PL, Gonzalez MO, Singh N, Zou J, Gonzales NR, Jones WJ, Alexandrov AW, Alexandrov AV, Navi BB, Nour M, Spokoyny I, Mackey J, Silnes K, Fink ME, Pisarro Sherman C, Willey J, Saver JL, English J, Barazangi N, Ornelas D, Volpi J, Pv Rao C, Griffin L, Persse D, Grotta JC. Outcomes of patients with pre-existing disability managed by mobile stroke units: A sub-analysis of the BEST-MSU study. Int J Stroke. 2023 Dec; 18(10):1209-1218.
Score: 0.046
-
Boehme AK, Siegler JE, Mullen MT, Albright KC, Lyerly MJ, Monlezun DJ, Jones EM, Tanner R, Gonzales NR, Beasley TM, Grotta JC, Savitz SI, Martin-Schild S. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):e255-61.
Score: 0.024
-
Sarraj A, Albright K, Barreto AD, Boehme AK, Sitton CW, Choi J, Lutzker SL, Sun CH, Bibars W, Nguyen CB, Mir O, Vahidy F, Wu TC, Lopez GA, Gonzales NR, Edgell R, Martin-Schild S, Hallevi H, Chen PR, Dannenbaum M, Saver JL, Liebeskind DS, Nogueira RG, Gupta R, Grotta JC, Savitz SI. Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke. Stroke. 2013 Dec; 44(12):3324-30.
Score: 0.023
-
Martin-Schild S, Hallevi H, Shaltoni H, Barreto AD, Gonzales NR, Aronowski J, Savitz SI, Grotta JC. Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia. J Stroke Cerebrovasc Dis. 2009 Mar-Apr; 18(2):86-96.
Score: 0.017
-
Barreto AD, Albright KC, Hallevi H, Grotta JC, Noser EA, Khaja AM, Shaltoni HM, Gonzales NR, Illoh K, Martin-Schild S, Campbell MS, Weir RU, Savitz SI. Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke. Stroke. 2008 Dec; 39(12):3231-5.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|